BioCentury
ARTICLE | Clinical News

Gestiva regulatory update

February 5, 2007 8:00 AM UTC

FDA granted Orphan Drug designation for Gestiva to prevent preterm birth in women with a history of preterm delivery. ADZA received an approvable letter from FDA for Gestiva requesting an additional a...